Ikapharmindo Putramas Tbk. vs Trimegah Bangun Persada Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 308.29B, 900 24h volume), while Trimegah Bangun Persada Tbk. trades at Rp845 (market cap 52.69T, 23.57M 24h volume). The key difference: Trimegah Bangun Persada Tbk. is far larger — about 170.9× Ikapharmindo Putramas Tbk.'s market cap, and Trimegah Bangun Persada Tbk. is more actively traded (23.57M versus 900). Which is the better fit depends on your goals.
| IKPM | NCKL | |
|---|---|---|
Market Cap | 308.29B | 52.69T |
Volume | 900 | 23.57M |
Lot | 9 | 235.74K |
Turnover | 164.2K | 19.79B |
Average Price | 182.44 | 839.43 |
Value | 164.2K | 19.79B |
Indicative Equilibrium Price | 183 | 840 |
Indicative Equilibrium Volume | 100 | 12.21K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Trimegah Bangun Persada Tbk. (the Company) was established in Indonesia based on Notarial Deed of Erna Priyono, S.H., No. 03 dated September 6, 2004.
Read more on NCKL →